Weight-loss medications are rapidly changing how millions of people approach food.
McDonald's is exploring ways to cater to the growing number of Americans taking GLP-1 weight-loss drugs, such as Ozempic and Wegovy, by testing high-protein menu items. CEO Chris Kempczinski revealed ...
Would you like to supersize that order? Not anymore. Restaurants built on big portions are facing a new reality: Customers on GLP-1 weight loss drugs like Ozempic, Wegovy and Zepbound can’t eat as ...